Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 5 | 2025 | 228 | 1.530 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2019 | 21 | 0.670 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 70 | 0.630 |
Why?
|
| Drug Utilization | 1 | 2019 | 158 | 0.610 |
Why?
|
| Flecainide | 1 | 2017 | 22 | 0.580 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 747 | 0.540 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 218 | 0.510 |
Why?
|
| Coronary Angiography | 3 | 2024 | 417 | 0.510 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 359 | 0.460 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 494 | 0.460 |
Why?
|
| Heart Ventricles | 2 | 2021 | 760 | 0.450 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 105 | 0.340 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2025 | 195 | 0.340 |
Why?
|
| Aortic Valve Stenosis | 2 | 2025 | 330 | 0.320 |
Why?
|
| Coronary Artery Bypass | 2 | 2023 | 487 | 0.300 |
Why?
|
| Atherosclerosis | 2 | 2023 | 831 | 0.220 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 195 | 0.200 |
Why?
|
| Acute Coronary Syndrome | 1 | 2025 | 202 | 0.200 |
Why?
|
| Prescriptions | 1 | 2019 | 39 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2025 | 12118 | 0.160 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 53 | 0.160 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 269 | 0.160 |
Why?
|
| Office Visits | 1 | 2019 | 76 | 0.160 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 203 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2019 | 278 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 217 | 0.150 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2017 | 60 | 0.140 |
Why?
|
| Stents | 1 | 2024 | 872 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 257 | 0.140 |
Why?
|
| Echocardiography, Doppler | 1 | 2017 | 170 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 428 | 0.140 |
Why?
|
| Aged | 5 | 2023 | 19082 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1237 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2019 | 1472 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 416 | 0.130 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 654 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2019 | 386 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1009 | 0.120 |
Why?
|
| Logistic Models | 1 | 2019 | 1789 | 0.120 |
Why?
|
| Cardiology | 1 | 2019 | 472 | 0.110 |
Why?
|
| Registries | 1 | 2019 | 1394 | 0.100 |
Why?
|
| United States | 4 | 2023 | 10639 | 0.100 |
Why?
|
| Veterans | 2 | 2021 | 1727 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 714 | 0.100 |
Why?
|
| Risk Factors | 3 | 2025 | 10006 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 123032 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2838 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2019 | 4702 | 0.090 |
Why?
|
| Blepharophimosis | 1 | 2010 | 26 | 0.090 |
Why?
|
| Aortic Valve | 2 | 2025 | 433 | 0.090 |
Why?
|
| Eyelids | 1 | 2010 | 115 | 0.080 |
Why?
|
| Blepharoptosis | 1 | 2010 | 67 | 0.080 |
Why?
|
| Female | 6 | 2023 | 65496 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16028 | 0.070 |
Why?
|
| Middle Aged | 3 | 2023 | 25980 | 0.070 |
Why?
|
| Male | 4 | 2023 | 60065 | 0.050 |
Why?
|
| Hospitals, Rural | 1 | 2020 | 8 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 24 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 6368 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2023 | 218 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 97 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2020 | 104 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 86 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2020 | 302 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 3042 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2019 | 374 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1260 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2019 | 377 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2020 | 340 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3315 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1495 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2799 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 613 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 29012 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5045 | 0.020 |
Why?
|
| Pakistan | 1 | 2010 | 77 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 186 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 367 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1115 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 1581 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 8849 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 13882 | 0.010 |
Why?
|